Evidence map›Paper›PMID 35533501›Full record

ArticleEBioMedicine2022

Medullary astrocytes mediate irregular breathing patterns generation in chronic heart failure through purinergic P2X7 receptor signalling.

Camilo Toledo, Esteban Díaz-Jara, Hugo S Diaz, Karla G Schwarz, Katherin V Pereyra, Alexandra Las Heras, Angélica Rios-Gallardo, David C Andrade, Thiago Moreira, Ana Takakura and 2 more

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Camilo ToledoLaboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile; Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Universidad de Magallanes, Punta Arenas, Chile.
Esteban Díaz-JaraLaboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile.
Hugo S DiazLaboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile.
Karla G SchwarzLaboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile.
Katherin V PereyraLaboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile.
Alexandra Las HerasLaboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile.
Angélica Rios-GallardoLaboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile.
David C AndradeLaboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile; Centro de Fisiología y Medicina de Altura, Facultad de Ciencias de la Salud, Universidad de Antofagasta, Antofagasta, Chile.
Thiago MoreiraDepartment of Physiology and Biophysics, Institute of Biomedical Science, University of Sao Paulo, Sao Paulo, SP, Brazil.
Ana TakakuraDepartment of Pharmacology, Institute of Biomedical Science, University of Sao Paulo, Sao Paulo, SP, Brazil.
Noah J MarcusDepartment of Physiology and Pharmacology, Des Moines University, Des Moines, IA, USA.
Rodrigo Del RioLaboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Alameda 340, Santiago, Chile; Centro de Envejecimiento y Regeneración (CARE), Pontificia Universidad Católica de Chile, Santiago, Chile; Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Universidad de Magallanes, Punta Arenas, Chile. Electronic address: rdelrio@bio.puc.cl.
Pontificia Universidad Católica de Chile · CLUniversidade de São Paulo · BRDes Moines University · USUniversidad de Antofagasta · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreathing disorders (BD) (apnoeas/hypopneas, periodic breathing) are highly prevalent in chronic heart failure (CHF) and are associated with altered central respiratory control. Ample evidence identifies the retrotrapezoid nucleus (RTN) as an important chemosensitivity region for ventilatory control and generation of BD in CHF, however little is known about the cellular mechanisms underlying the RTN/BD relationship. Within the RTN, astrocyte-mediated purinergic signalling modulates respiration, but the potential contribution of RTN astrocytes to BD in CHF has not been explored.

methodsSelective neuron and/or astrocyte-targeted interventions using either optogenetic and chemogenetic manipulations in the RTN of CHF rats were used to unveil the contribution of the RTN on the development/maintenance of BD, the role played by astrocytes in BD and the molecular mechanism underpinning these alterations.

findingsWe showed that episodic photo-stimulation of RTN neurons triggered BD in healthy rats, and that RTN neurons ablation in CHF animals eliminates BD. Also, we found a reduction in astrocytes activity and ATP bioavailability within the RTN of CHF rats, and that chemogenetic restoration of normal RTN astrocyte activity and ATP levels improved breathing regularity in CHF. Importantly, P"X/ P2X7 receptor (P2X7r) expression was reduced in RTN astrocytes from CHF rats and viral vector-mediated delivery of human P2X7 P2X7r into astrocytes increases ATP bioavailability and abolished BD.

interpretationOur results support that RTN astrocytes play a pivotal role on BD generation and maintenance in the setting CHF by a mechanism encompassing P2X7r signalling.

fundingThis study was funded by the National Research and Development Agency of Chile (ANID).

Indexed as

AstrocytesHeart FailureReceptors, Purinergic P2X7Respiration DisordersAdenosine TriphosphateAnimalsChemoreceptor CellsRatsAdenosine TriphosphateReceptors, Purinergic P2X7AstrocyteChronic heart failureDisordered breathingP2X7 receptorRetrotrapezoid nucleus

Identifiers

PMID35533501
PMCPMC9097632
OpenAlexW4229372041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.